1000
Vol. 50, No. 7
1
7.73. Found: C, 66.18; H, 8.63; N, 7.77. APCI-MS: m/z 182 [MϩH]ϩ. H-
Experimental
NMR (methanol-d4): Table 1.
General All melting points were measured with a Yanaco MP-S3 appa-
ratus and are uncorrected. Nuclear magnetic resonance spectra were ob-
tained at 500 MHz by means of a JEOL GSX-500 instrument (JEOL, Tokyo,
Japan). Solutions were prepared in chloroform-d or methanol-d4 and tetra-
methylsilane (TMS) serves as the internal reference. Mass spectrometric ex-
periments were performed using a TSQ-7000 triple stage quadruple mass
spectrometer (Thermo Quest, San Jose, CA, U.S.A.) operating with APCI,
connected with an HP series 1050 HPCL (Hewlett-Packard, Palo Alto, CA,
U.S.A.). Chromatography was conducted at ambient temperature on an Ex-
celpack SIL-C18/5 reverse-phase C18 column (5 mm, 5ϫ150 mm) (Yoko-
gawa, Tokyo, Japan) and Capcell Pack C18 reverse-phase C18 column (5 mm,
4.6ϫ150 mm) (Shiseido, Tokyo, Japan) operated at flow-rate of 0.6 ml/min
with eluent CH3OH–H2O (80 : 20) for 1 and CH3OH–H2O (70 : 30) for 3 and
5. The mass spectrometer was operated in the positive ion mode with the va-
porizer at 500 °C and the capillary at 175 °C. Nitrogen was used as the
sheath gas (70 psi) to assist neblization. The electron multiplier was set at
1000 V.
References
1) Georgiev V. St., Radov L. A., Kinsolving C. R., Griffith R. C., Zazulak
W. I., Kamp D. K., Trusso L. A., Mark R. A., Eur. J. Med. Chem.-
Chim. Ther., 21, 315—319 (1986).
2) Katagi T., Kataoka H., Takahashi K., Fujioka T., Kunitomo M., Yama-
guchi Y., Fujiwara M., Inoi T., Chem. Pharm. Bull., 40, 2419—2422
(1992).
3) Kramer J. B., Capiris T., Sircar J. C., Connor D. T., Bornemeier D. A.,
Dyer R. D., Kuipers P. J., Kennedy J. A., Wright C. D., Okonkwo G. C.
N., Lesch M. E., Schrier D. J., Boschelli D. H., Bioorg. Med. Chem., 3,
403—410 (1995).
4) Katagi T., Kataoka H., Konishi Y., Takata Y., Kitano S., Yamaki M.,
Inoi T., Yamamoto K., Yamamoto S., Yamagata Y., Chem. Pharm.
Bull., 44, 145—149 (1996).
5) Horiyama S., Suwa K., Yamaki M., Kataoka H., Katagi T., Takayama
M., Rapid Commun. Mass Spectrom., 9, 971—977 (1995).
6) Horiyama S., Suwa K., Yamaki M., Kataoka H., Katagi T., Takayama
M., Eur. Mass Spectrom., 5, 203—211 (1999).
Calibration 1, 3 and 5 were dissolved in chloroform to 10 mM (stock
solution) and further calibration levels were prepared by diluting the stock
solution.
7) Benington F., Morin R. D., Clark L. C., Jr., J. Med. Chem., 8, 100—
104 (1965).
8) Beckett A. H., Al-Sarraj S., J. Pharm. Pharmacol., 25, 328—334
(1973).
9) Beckett A. H., Rashid Purkaystha A., Morgan P. H., J. Pharm. Phar-
macol., 29, 15—21 (1977).
10) Lindeke B., Anderson E., Acta Pharm. Suec., 12, 183—198 (1975).
11) Borch R. F., Bernstein M. D., Durst H. D., J. Amer. Chem. Soc., 93,
2897—2904 (1971).
Sample Preparation for LC-MS 1, 3 and 5 dissolved in He-degassed
methanol, chloroform, ethanol, pyridine, methylamine, benzene and toluene
to 1 mM, and 3 ml was injected at set intervals of about 24 h or more.
Synthesis Hydroxylamines 1,6) 3 and 5 were prepared from 2, 4 and 6
by modification of Borch’s11) method using NaBH3CN. Oximes 2, 4 and 6
were prepared from the corresponding methylketone with hydroxylamine in
the usual way.12)
1-Hydroxylamino-1-(4Ј-piperidinophenyl) Ethane (1)6): 1H-NMR
(methanol-d4): Table 1.
12) Buck J. S., Ide W. S., “Organic Syntheses,” Coll. Vol. II, ed. by Blatt
A. H., John Wiley and Sons, Inc., New York, 1943, p. 622.
13) Lindeke B., Cho A. K., Thomas T. L., Michelson L., Acta Pharm.
Suec., 10, 493—506 (1973).
1-Hydroxylamino-1-(4Ј-morpholinophenyl) Ethane (2): mp 111.5—
113 °C (from ethyl acetate). Anal. Calcd for C12H18N2O2: C, 64.84; H, 8.16;
N, 12.60. Found: C, 64.69; H, 8.41; N, 12.59. APCI-MS: m/z 223 [MϩH]ϩ.
1H-NMR (methanol-d4): Table 1.
14) McMurry J., “Organic Chemistry,” Brooks/Cole, U.S.A., 1999, p. 660
and p. 985.
2-Hydroxylamino-1-(4Ј-mothoxyphenyl) Propane (3): mp 65—67 °C
(from petroleum ether). Anal. Calcd for C10H15NO2: C, 66.27; H, 8.34; N,